Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vivani Medical, Inc.

1.04
+0.0000
Post-market: 1.060.0199+1.91%16:06 EDT
Volume:28.92K
Turnover:30.35K
Market Cap:61.61M
PE:-2.43
High:1.06
Open:1.05
Low:1.04
Close:1.04
Loading ...

Company Profile

Company Name:
Vivani Medical, Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
37
Office Location:
1350 South Loop Road,Alameda,California,United States
Zip Code:
94502
Fax:
- -
Introduction:
Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.

Directors

Name
Position
Gregg Williams
Chairman
Will McGuire
President, Chief Executive Officer and Director
Aaron Mendelsohn
Director
Alexandra Larson
Director
Dean Baker
Director
Matthew Pfeffer
Director

Shareholders

Name
Position
Will McGuire
President, Chief Executive Officer and Director
Edward Randolph
Vice President
Edward Sedo
Acting Chief Accounting Officer
Jessy Dorn
Vice President of Clinical and Scientific Affairs
Scott Dunbar
Acting CEO